The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014-2018): an analysis of data from the national Antimicrobial Resistance Surveillance system.
Dunja SaidNiklas WillrichOlaniyi AyobamiInes NollTim EckmannsRobby MarkwartPublished in: Antimicrobial resistance and infection control (2021)
In contrast to many other regions worldwide, carbapenem resistance proportions among clinical A. baumannii complex isolates are relatively low in Germany and have declined in the last few years. Ongoing efforts in antibiotic stewardship and infection prevention and control are needed to prevent the spread of carbapenem-resistant A. baumannii complex in Germany.
Keyphrases
- acinetobacter baumannii
- multidrug resistant
- drug resistant
- antimicrobial resistance
- pseudomonas aeruginosa
- klebsiella pneumoniae
- quality improvement
- magnetic resonance
- public health
- electronic health record
- risk factors
- cystic fibrosis
- computed tomography
- magnetic resonance imaging
- machine learning
- escherichia coli
- artificial intelligence